HKSE · 1177.HK
Sino Biopharmaceutical Limited
HK$4.86+HK$0.01 (+0.1%)
Sino Biopharmaceutical Limited’s quoted price sits in the lower half of its reported 52-week range, 35.09% below the high.
Loading market information…
OTC · ZHYBF · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited Limited is based in Wanchai, Hong Kong.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$4.86+HK$0.01 (+0.1%)
Sino Biopharmaceutical Limited’s quoted price sits in the lower half of its reported 52-week range, 35.09% below the high.
HK$37.76+HK$0.06 (+0.16%)
Genscript Biotech Corporation’s quoted price sits in the upper half of its reported 52-week range, 23.66% below the high.
$0.65$0.00 (0.0%)
Goldenwell Biotech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.71% below the high.
$3.16-$0.02 (-0.63%)
TAO Synergies Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.89% below the high.
$0.10-$0.05 (-33.33%)
NDT Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.24% below the high.
$0.20$0.00 (0.0%)
Hanjiao Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.26$0.00 (0.0%)
AiXin Life International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.81% below the high.
$0.02-$0.00 (-8.26%)
China Medicine Corp.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
